Metraipolis › archive › dc_ee39e09118ab

Clinical implications of a novel SERPINA1 variant c.236 T > A: Challenges in characterizing new rare alpha-1 antitrypsin mutations — Europe PMC PMID:41732190

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41732190
DOI
10.1016/j.ymgmr.2026.101295
License (as archived)
solo-consultazione
Archived
2026-11-05T20:34:38.253Z
SHA-256 of the archived text
52f3c23b414ff68b9b68c45d1c0c044c6a7c0bbed50ce88ca4ef9c48997e9989
Stable URL of this page
https://metraipolis.com/documento/dc_ee39e09118ab

How to cite

Clinical implications of a novel SERPINA1 variant c.236 T > A: Challenges in characterizing new rare alpha-1 antitrypsin mutations — Europe PMC PMID:41732190 — Europe PMC (en), https://europepmc.org/article/MED/41732190 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee39e09118ab (Metraipolis archive dc_ee39e09118ab, sha256 52f3c23b414ff68b9b68c45d1c0c044c6a7c0bbed50ce88ca4ef9c48997e9989)
BibTeX
@misc{dcee39e09118ab,
  title = {Clinical implications of a novel SERPINA1 variant c.236 T > A: Challenges in characterizing new rare alpha-1 antitrypsin mutations — Europe PMC PMID:41732190},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41732190},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee39e09118ab; sha256 52f3c23b414ff68b9b68c45d1c0c044c6a7c0bbed50ce88ca4ef9c48997e9989},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41732190. Agents can read the archived copy with the MCP tool read_document.